ABSTRACT: Dissolution of the inorganic phase of bone by the osteoclasts mediated by V-ATPase and ClC-7 is a prerequisite for bone resorption. Inhibitors of osteoclastic V-ATPase or ClC-7 are novel approaches for inhibition of osteoclastic bone resorption. By testing natural compounds in acidification assays, diphyllin was identified. We characterized diphyllin with respect to the pharmacological effects on osteoclasts.
INTRODUCTION

B
ONE IS A dynamic tissue, which is continuously remodeled throughout life, not only to maintain calcium homeostasis, but also to repair microdamage and thereby maintain bone quality. (1) This continuous remodeling of bone involves the osteoclasts that strive to achieve a coordinated and balanced resorption of old bone, and the osteoblasts, which are responsible for adequate formation of new bone, in a local, coordinated and sequential manner referred to as coupling. (2) (3) (4) (5) The coupling process is understood as a bone formation response that results from bone resorption, with the amount of bone formed equal to that resorbed. (2) (3) (4) (5) (6) (7) Uncoupling occurs when the balance between formation and resorption is dissociated, which can lead to either osteopetrosis or osteoporosis. (8, 9) Although it has long been appreciated that bone formation is tightly coupled to bone resorption in normal adult bone turnover, (1) this coupling can be dissociated in some circumstances, for example, during skeletal growth, in postmenopausal osteoporosis, and in some but not all osteopetrotic mutations. (4, 10) The resorption of the mineralized bone matrix mediated by osteoclasts occurs during active secretion of protons through a V-ATPase, (11) (12) (13) (14) which is followed by passive Dr Karsdal owns stock in Nordic Bioscience. All other authors state that they have no conflicts of interest. 1 Nordic Bioscience A/S, Herlev, Denmark; transport of chloride ions through ClC-7 to maintain electroneutrality. (15) (16) (17) (18) V-ATPases are a class of ATP-driven multisubunit proton pumps found in all eukaryotic cells, including osteoclasts. (19) The osteoclast V-ATPase contains a specific subunit, the a3 subunit. (20, 21) "Loss of function" mutations in the a3 subunit lead to severe osteopetrosis in both humans and mice, caused by reduced acidification of the resorption lacuna. (12, 14, 22) In humans, osteopetrosis caused by mutations in proteins (ClC-7 or a3-V-ATPase) involved in the acidification of the osteoclastic resorption lacuna have decreased resorption in face of normal or even increased bone formation. (23, 24) This is most prominently found in the patients harboring a mutation in a3-V-ATPase who have a direct linear relationship between osteoclast number, not activity, and the number of active osteoblasts. (25) In alignment, inhibition of bone resorption by inhibitors of acidification of the resorption lacuna is achieved without the secondary negative effects on bone formation, which is in contrast to most if not all other antiresorptives. (26, 27) Thus, acidification inhibitors, and even natural compounds with acidification inhibitory properties, may constitute a novel approach for treatment of bone related diseases.
We studied an array of natural compounds for their ability to inhibit acidification using an acridine orange-based acidification assay. We identified the natural compound diphyllin as a potent V-ATPase inhibitor. Diphyllin has long been tested for pharmacological effects in other biological systems; however, to date, no precise molecular mode of action has been presented. We characterized this compound with respect to pharmacological effects on human osteoclasts.
MATERIALS AND METHODS
Compounds
Diphyllin [1-hydroxy-2-(hydroxymethyl)-6,7-dimethoxy-4-(3,4-methylenedioxy-phenol)-3-naphthoic acid-␥-lactone] used in this study was synthesized by Asinex (BAS 00442101). The chemical structure of diphyllin is shown in Fig. 1 . Bafilomycin A1 was purchased from Calbiochem. The remaining chemicals were from Sigma-Aldrich, and the culture media were from Invitrogen unless specified.
Bovine chromaffin granules
Bovine chromaffin granules (BCGs) were isolated from the medullae of bovine adrenal glands according to a previously published protocol. (28) The adrenal glands were obtained at a local slaughterhouse, and the medullary section was cut free. The medullae were homogenized and ultracentrifuged on a two-layer sucrose gradient, and the subsequent pellet was resuspended and stored at −80°C. The BCGs were used for both the influx assay and the VATPase assay.
Influx assay
The influx assay was performed as previously described, (16) Briefly, BCGs were incubated in reaction buffer (5 mM HEPES, 150 mM KCl, 5 mM MgSO 4 , 1.5 M acridine orange, and 1 M valinomycin), and the inhibitors were added as described in the figure legends. The reaction was incubated at room temperature for 30 min. The reaction was initiated by addition of ATP at a final concentration of 5 mM to the wells and immediately after the plate was read in a plate reader using excitation of 492 nm and emission of 535 nm. The fluorescence was read every 15 s, and the results are presented as the slope of the curves in percent of the vehicle condition. To ensure that the compounds had no effect on the fluorescence, the plate was read before addition of ATP to obtain a steady-state level (data not shown).
V-ATPase assay
V-ATPase activity was assayed using a modification of a previously published protocol. (29) Briefly, the BCGs were incubated in the assay buffer (25 mM Tris-HCl, 50 mM KCl, 2.5 mM MgSO 4 , 0.5 mM EGTA, 3 mM DTT, 3 mM ATP, 2 mM ouabain, 3 mM NaN 3 ), and to eliminate contribution from P-ATPases and F-ATPases, sodiumvanadate (0.5 mM) and oligomycin (5 g/ml) were included. The desired compound was added as described in the figure legends. The reaction was performed at 37°C for 1 h and placed on ice to stop the reaction. Finally, the level of free phosphate was measured by addition of molybdate reagent (1.8 mM ammonium molybdate, 270 mM H 2 SO 4 , and 1% [wt/vol] ascorbic acid). Finally, the results were quantified by measuring absorbance at 750 nm. As background, samples incubated on ice were used, and these results were subtracted from the values obtained at 37°C.
Isolation of CD14+ human monocytes
The CD14+ isolation was performed as previously described. (30) (31) (32) Briefly, the monocytes were isolated from 
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peripheral blood by centrifugation on a Ficoll-Paque gradient (Amersham Pharmacia), and magnetically sorted using a CD14+ magnetic bead isolation kit (Dynabeads M-450; Dynal Biotech). The cells were either seeded in 75-cm 2 flasks for resorption or in 96-well plates for acidification experiments and cultured in ␣MEM containing 10% FBS, 100 units/ml penicillin, 100 g/ml streptomycin, 25 ng/ml of macrophage-colony stimulating factor (M-CSF; R&D Systems), and 25 ng/ml RANKL (R&D Systems) for 10-12 days. When mature osteoclasts were present in the culture flasks, the cells were lifted and seeded on cortical bovine bone slices in the presence or absence of diphyllin for the bone resorption experiments.
Cortical bovine bone slices
The bone slices were cut from sticks (Nordic Bioscience Diagnostics), which were made of the cortical bone from cows. The sticks were cut into small slices with a thickness of 0.2 mm with a diameter that fits into 96-well plates.
Osteoclast acidification assay
Acridine orange (3,6-bis[Dimethylamine]acridine) at 10 g/ml was loaded for 45 min in the culture medium in the presence or absence of various inhibitors. The dye was washed away, and pictures were taken using an OLYMPUS IX-70 microscope and an OLYMPUS U-MWB filter (×20 objective) or the fluorescence was measured using the SpectraMax Gemini XS at excitation of 492 nm and emission of 535 nm.
Resorption assays
The release of the C-terminal type I collagen fragments (CTX-I) from cortical bovine bone slices was determined using the CrossLaps for Culture kit (Nordic Bioscience Diagnostics) according to the manufacturer's instructions.
Measurement of calcium
The concentration of total calcium was measured in culture supernatants after resorption was measured using a colorimetric assay and a Hitachi 912 Automatic Analyzer (Roche Diagnostics).
Immunolocalization of the calcitonin receptor
At the end of the culture, the osteoclasts were fixed in 3.7% formaldehyde in PBS for 20 min and thoroughly washed in PBS. This was followed by blocking of nonspecific binding in TBS containing 0.5% casein for 30 min at ambient temperature. The primary antibody (anti-human calcitonin receptor; Serotech) was diluted in TBS/CAS and added to the specimens and incubated at 4°C overnight. The specimens were washed three times in TBS, and Mouse Envision (Dakocytomation) was used as the secondary antibody. Finally, the peroxidase activity was visualized using DAB+, and the specimens were counterstained using Ehrlich's hematoxylin.
Scoring of calcitonin receptor-positive cells
The osteoclasts were counted using an Olympus IX-70 microscope linked to a computer using the CAST-GRID program (Olympus). The cells were scored as osteoclasts when a clear calcitonin receptor staining was seen. The results are presented as number of cells relative to the vehicle-treated controls.
Resorption pits
After termination of the experiment, the bone slices with cells were washed in milliQ water. The cell remnants were removed using a cotton swab. The pits were stained for 7-8 min in Mayer's hematoxylin, and finally the bone slices were washed in milliQ water. The resorbed area was measured using CAST-Grid. The results are shown as resorbed area relative to the total area of bone.
Osteoblastogenesis
The mouse osteoblastic cell line, MC3T3-E1, was seeded in 12-well plates at a density of 150,000 cells/well and differentiated into osteoblasts by growing them in ␣-MEM containing 10% FBS, 100 units/ml penicillin, 100 g/ml streptomycin, 50 g/ml ascorbic acid, and 10 mM ␤-glycerol phosphate. The cells were incubated in the absence or presence of either bafilomycin A1 or diphyllin and grown for 21 days with a change of medium every second day.
Alizarin red staining of bone nodules
After 21 days of incubation, the MC3T3-E1 cells were fixed in 3.7% buffered formaldehyde, and stained with 40 mM Alizarin red-S, pH 4.2, for 10 min. The cells were washed five times in milliQ water and in PBS for 15 min. The Alizarin red dye was extracted from the cells by addition of 10% cetylpyridinium chloride in PBS and incubation for 1 h with shaking in the dark. The extracted dyes were transferred to a 96-well plate, and the alizarin red staining was quantified by measuring absorption at 561 nm.
Statistics
Statistical analyses were performed using one-way ANOVA followed by Dunnett's multiple comparison tests. Bartlett's test was used to assess variance homogeneity. Statistical significance is indicated by the number of asterisks: *p < 0.05 and ***p < 0.001.
RESULTS
Diphyllin inhibited acidic influx in isolated vesicles from bovine adrenal medullae
Diphyllin inhibited the acid influx in the BCGs potently, with an IC 50 of 0.6 nM ( Fig. 2A) . In comparison, the known H + -V-ATPase inhibitor bafilomycin A1 inhibited the acid influx with an IC 50 value of 0.4 nM (Fig. 2B ).
Diphyllin is a potent H + -V-ATPase inhibitor
Because acid influx is dependent on both proton and chloride transport, (15) we studied whether diphyllin showed inhibitory activity in an H + -V-ATPase assay using the BCGs, which contain high levels of H + -V-ATPase activity. (28) Diphyllin was found to inhibit H + -V-ATPase activity (Fig. 3A) with an IC 50 (Fig. 3B) .
Diphyllin inhibited osteoclastic acidification
We used acridine orange dye to study the response of diphyllin on the acidification in human osteoclasts. (33) As seen in Fig. 4A , osteoclasts in the absence of inhibitors show orange fluorescence, indicating the formation of a resorption lacuna. Addition of diphyllin dose-dependently inhibited acidification, and a complete abrogation of the orange signal was observed at 1 M. The known H + -VATPase inhibitor bafilomycin A1 was used as a positive control, and as expected, it completely inhibited acidification at 200 nM. (26, 34) The acidification was quantified by measurement of acidification mediated quenching of acridine orange. As seen in Figs. 4B and 4C, diphyllin and bafilomycin A1 both inhibited the acidification dosedependently resulting in a lower quenching, and thus a higher fluorescence, respectively.
Diphyllin potently inhibited osteoclast-mediated resorption
To study the effect of diphyllin on human osteoclastic bone resorption, human osteoclasts were seeded on cortical bovine bone slices and allowed to attach and initiate bone resorption for 1 day.
Diphyllin dose-dependently inhibited bone resorption with an IC 50 value of 14 nM (Fig. 5A) . Interestingly, cell viability was significantly increased compared with controls ( Fig. 5B) , indicating increased survival of osteoclasts when resorption is inhibited. (26) TRACP activity was also increased by diphyllin (Fig. 5C) . Furthermore, the number of calcitonin receptor-positive cells was increased (Fig. 5D) , confirming that diphyllin augmented osteoclast survival, in alignment with previously published effects of the known H + -V-ATPase inhibitor bafilomycin A1. (26) However, when diphyllin was used at 3 M, we observed a decrease in cell viability, osteoclast number, and TRACP activity. We further characterized the effect of diphyllin on resorption by assessing the calcium release from bone slices. Diphyllin inhibited calcium release from the bone slices during osteoclastic bone resorption, with an IC 50 value of 49 nM (Fig. 5E) . Finally, diphyllin decreased the resorbed bone area dose-dependently (Fig. 5F) , with an IC 50 value of 29 nM, correlating with the CTX-I values. All these data correlated well with results obtained using 10 nM bafilomycin A1 (Figs. 5A-5F ).
Diphyllin had no effect on osteoblastic bone formation
To study the effect of diphyllin on osteoblastic bone formation, the mouse osteoblastic cell line, MC3T3-E1, was seeded on plastic and cultured in the presence or absence of diphyllin for 21 days. The positive control BMP-2 induced bone formation (data not shown) as expected. (35) Diphyllin showed no cytotoxic effects on the osteoblasts up to 100 nM (Fig. 6B ) and showed no effect on the bone formation induced by ␤-glycerol phosphate and ascorbic acid (Fig. 6A) . In comparison, bafilomycin A1 showed strong cytotoxic effects on the osteoblasts already at 10 nM (Fig. 6B) , and thus minimal bone formation was present (Fig. 6A) .
DISCUSSION
Diphyllin has long been tested for pharmacological effects in other biological systems; however, to date, no precise molecular mode of action has been presented. In this study, we identified and characterized diphyllin as a novel and potent inhibitor of V-ATPase, and through that, osteoclastic bone resorption. These data are the first to describe a precise molecular mode of action of diphyllin, although several effects have been suggested at much higher concentrations than used in this study.
By testing selected natural compounds for their ability to inhibit acidification in an acid influx assay, we identified diphyllin. We found that diphyllin potently inhibited H + -VATPase. We characterized the compound diphyllin with respect to an array of osteoclastic properties and found that it, through inhibition of H + -V-ATPase, strongly inhibited lysosomal acidification and acidification of the resorption lacunae, resulting in highly potent inhibition of bone resorption. Moreover, diphyllin showed no effect on bone formation in vitro, indicating that diphyllin has a different mode of action than the structurally unrelated compound bafilomycin A1.
Recent studies indicated that inhibition of the osteoclastic acidification leads to inhibition of bone resorption without bone inhibiting formation. (26, 27) In these studies, an augmented number of osteoclasts was proposed to be one potential source of the stimulatory effects on bone formation. (17, 25, 27) In this study, diphyllin mediated a dosedependent decrease in bone resorption measured by pit area, collagen type I degradation (CTX-I release), and release of calcium, in face of dose-dependent increases in cell viability, osteoclast number, and TRACP activity. These findings are in alignment with the osteopetrotic mutations in the a3 subunit of the osteoclastic V-ATPase and in ClC-7, in which acidification of the osteoclastic resorption lacunae is attenuated. (17, 23, 26) In osteopetrotic patients, TRACP activity is increase by >300%. (36) (37) (38) Furthermore, inhibition of acidification of the osteoclastic resorption lacunae by a ClC-7 inhibitor resulted in increased numbers of osteoclasts, (26) which is in line with both osteopetrotic patients and these findings using diphyllin. Diphyllin did not completely abrogate acidification of the resorption lacuna, based on acridine orange measurements, at the concentrations where increased survival was observed. Because recent studies indicate that bone formation is correlated to osteoclast numbers, (25) novel antiresorptives strategies may allow inhibition of osteoclastic resorption, while sustaining osteoclast numbers, thereby possibly avoiding the secondary decrease in bone formation. (26, 27, 39, 40) When diphyllin was used at 3 M, we observed a decrease in cell viability, osteoclast number, and TRACP activity, indicating that diphyllin is either toxic or promotes apoptosis of the cells at concentrations >3 M. The same phenomenon was observed with bafilomycin A1 (data not shown) in alignment with previous publications. (41, 42) The concentrations where diphyllin exhibited cytotoxic effects on the osteoclasts far exceeded those needed for inhibition of V-ATPase and thereby bone resorption.
Until now, only few H + -V-ATPase inhibitors have been found, such as the natural compounds bafilomycin A1, (34, 43) concanamycin, (43) and Iejimalides (IEJL-A and IEJL-B), (44) as well as the synthetic inhibitors FR167356 (45) and SB242784. (46) All these compounds potently inhibit osteoclastic resorption through inhibition of the acidification of the resorption lacuna, although the natural compounds are >100-fold more potent than their synthetic counterparts. (34, 43, 45, 46) In addition to the bone-related effects, evidence for an anti-inflammatory effects of V-ATPase inhibitors was shown in an adjuvant induced arthritis (AIA) model, where both inflammation and bone destruction were reduced. (47, 48) Because of its potency and its properties as a natural product, diphyllin could potentially benefit many patient groups.
The V-ATPase assay was done including inhibitors of the known classes of ATPases in the presence and absence of V-ATPase inhibitors as previously published. (48) (49) (50) Furthermore, there are no data present that indicate that bafilomycin A1 inhibits other ATPases than V-ATPase, and thus there is no reason to believe that the effect of diphyllin is mediated by inhibition of other enzymes.
Diphyllin is a plant-derived lignan, which previously was studied for cytotoxicity on cancer cells and antiinflammatory effects. However, in these studies, the concentrations used exceeded the concentrations needed to inhibit osteoclastic resorption by a factor ranging between 1000 and 10,000. (51) (52) (53) (54) (55) In addition, the mode of action behind these effects was unknown. (51) (52) (53) (54) (55) Moreover, high concentrations of diphyllin (IC 50 > 30 M) were shown to have an antiproliferative activity toward human monocytes. (56) Diphyllin was found to attribute to the toxicity of the plant Cleistanthus collinus together with its glycosides cleistanthin A, cleistanthin B, and collinusin. (57) An effect of the plant Cleistanthus collinus has been recorded with respect to glutathione depletion and adenosine triphosphatase (Na + , K + -ATPase, and Mg 2+ -ATPase) inhibition in liver, kidney, heart, brain, and skeletal muscles, (57) although whether these effects are caused by diphyllin or other plantreactive species remain to be studied.
In conclusion, we characterized the natural compound diphyllin and identified the mode of action underlying its effects. Diphyllin was characterized as a novel potent VATPase inhibitor, which abrogates acidification of the osteoclastic resorption lacunae and thereby bone resorption. We speculate that diphyllin is a potential novel treatment for bone disorders involving excessive resorption.
FIG. 6.
Diphyllin did not inhibit osteoblastic bone formation. MC3T3-E1 cells were seeded in 12-well plates at a density of 150,000 cells/well and grown in medium supplemented with ascorbic acid and ␤-glycerol phosphate to differentiate the cells into osteoblasts. After 1 day of culture, 10 nM bafilomycin and different concentrations of diphyllin (100, 30, and 10 nM) were added to the cells. After 21 days of culture, the cell viability was measured by AlamarBlue (B), and the bone nodule formation was determined by quantification of alizarin red staining (A). *Significant differences between vehicle-and inhibitor-treated conditions.
